About this episode

A panel of industry experts discusses the deployment of AI and machine learning in biologics R&D at PEGS Boston.

At this year’s PEGS Boston, industry experts gathered on a panel to explore how AI and machine learning are deployed in biologics R&D today. Moderated by Peter M. Tessier, Ph.D., Albert M. Mattocks professor of pharmaceutical sciences and chemical engineering at University of Michigan, the panel consisted of Andrew Buchanan, Ph.D., head of discovery at a stealth-mode biotech company; Norbert Furtmann, Ph.D., head of biologics AI and design of large molecules research at Sanofi; Konrad S. ...

People in this episode

Host: Peter M. Tessier, Ph.D.

Guests: Andrew Buchanan, Ph.D., Norbert Furtmann, Ph.D.

Topics covered

• AI in biotherapeutics
• machine learning
• biologics R&D
• panel discussion
• industry challenges

Keywords

• AI
• machine learning
• biologics
• R&D
• biotherapeutics
• panel discussion
• industry experts

Mentioned in this episode

Organizations: University of Michigan, Sanofi

Explore listener stats, chart rankings, contacts and more on the The Chain: Protein Engineering Podcast podcast page.